Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery

MilliporeSigma's Shiksha Mantri, Ph.D., explains how lipid nanoparticle delivery systems are enabling the development of RNA-based therapies, recent advances in the field, and new opportunities on the horizon.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: